Many Generic Drugs Haven’t Hit Market, Hindering Cost-Control Efforts

📆 2019-11-20 오전 11:00:00
📰 WSJ

⏱ Reading Time:
9 sec. here
2 min. at publisher
📊 Quality Score:
News: 7%
Publisher: 63%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

To curb high drug costs, the U.S. has approved record numbers of generic drugs in recent years. But only a fraction have gone on sale.

Record numbers of generic drugs for cancer, heart ailments and other conditions have received U.S. approval in recent years, raising hopes that the new competition would reduce high drug costs. But many of the lower-price medicines haven’t hit the market, a Wall Street Journal review found.

The result: Many patients are forced to take high-price medicines, and a widely touted remedy for reining in drug costs has failed to live up to its promise.

댓글 쓰기

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Double-whammy of Brexit and election hits UK housing market - surveyThe number of properties put up for sale in Britain has fallen by the most in an...
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »